AMA CPT® Assistant - 2006 Issue 1 (January)
Multiple Molecular Marker Array-Based Evaluation (January 2006)
January 2006 pages 5-6 Coding Communication:Multiple Molecular Marker Array-Based Evaluation Knowledge of the role that genetic mutations play in neoplastic and non-neoplastic disease together with the number of implicated genetic aberrations continues to increase, driven, in part, by new analytic methods. One of these is arraybased technology, which provides a platform that is rapidly advancing the study of molecular diagnostic abnormalities associated with a number of different diseases. Results from this testing are used to interpret, diagnose, and monitor disease states and to direct therapeutic intervention. They may also identify preclinical and carrier states to identify patients predisposed to...
To read the full article, sign in and subscribe to the AMA CPT® Assistant.
Thank you for choosing Find-A-Code, please Sign In to remove ads.